Groups Ask FDA to Keep Zohydro ER Hydrocodone Off the Market (FREE)

By Kelly Young A coalition of consumer safety organizations, addiction treatment providers, and healthcare groups has asked the FDA to reconsider its approval of the high-dose hydrocodone capsule Zohydro ER because of its abuse potential. …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news